3 ms·
A huge chunk of corporate bio R&D now goes into finding workaround reimplementations for patented publicly funded research. Just opening public research wouldn
by cma 2y ago
A huge chunk of corporate bio R&D now goes into finding workaround reimplementations for patented publicly funded research.
Just opening public research wouldn't help us get remuneration from overseas use though unfortunately.
- idunnoman1222 2y agoAnd making sure you don’t accidentally violate a patent when you’re just going down the most obvious path